Literature DB >> 11328364

Inducible nitric oxide synthase expression in gastroduodenal diseases infected with Helicobacter pylori.

H J Son1, J C Rhee, D I Park, Y H Kim, P L Rhee, K C Koh, S W Paik, K W Choi, J J Kim.   

Abstract

BACKGROUND: Nitric oxide (NO) is synthesized enzymatically from L-arginine by NO synthase, which is measured by inducible NO synthase (iNOS). Helicobacter pylori (H. pylori) infection produces a state of chronic immunostimulation in the gastric epithelium. Infection with cagA+ H. pylori has greater degree of gastric inflammation and epithelial cell damage. Therefore, we compared the levels of iNOS in patients with H. pylori infection in relation to cagA status and H. pylori-related disease.
MATERIALS AND METHODS: One hundred and seven patients, including 51 patients with gastric cancer, 12 patients with gastric ulcer, 18 patients with duodenal ulcer and 26 patients with chronic gastritis, were enrolled in this study. Biopsies from the antrum and body were obtained for histologic examination, culture and reverse transcriptionase-PCR (RT-PCR) for detection of iNOS gene expression. The presence of H. pylori was confirmed by Giemsa staining or culture and the gene expression of cagA in H. pylori isolates was confirmed by PCR.
RESULTS: H. pylori infection was detected in 70.1% (75/107) and cagA was detected in 84.8% (28/33). iNOS expression was detected in 49.5% (53/107) and there was no significant difference in iNOS expression according to H. pylori infection nor the cagA status in the gastroduodenal diseases. However, iNOS expression was more frequently detected in gastric cancer than the other H. pylori-related diseases (64.7% vs. 35.7%, p <.05).
CONCLUSION: Although NO was thought be involved in the gastric carcinogenesis, the level of NO production was not related to H. pylori infection or cagA status.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11328364     DOI: 10.1046/j.1523-5378.2001.00004.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  10 in total

1.  Differences in oxidative stress dependence between gastric adenocarcinoma subtypes.

Authors:  Brigitte Bancel; Jacques Esteve; Jean-Christophe Souquet; Shinya Toyokuni; Hiroshi Ohshima; Brigitte Pignatelli
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

Review 2.  The Immune Battle against Helicobacter pylori Infection: NO Offense.

Authors:  Alain P Gobert; Keith T Wilson
Journal:  Trends Microbiol       Date:  2016-02-22       Impact factor: 17.079

3.  Gastric helicobacter infection induces a Th2 phenotype but does not elevate serum cholesterol in mice lacking inducible nitric oxide synthase.

Authors:  Melanie Ihrig; Mark T Whary; Charles A Dangler; James G Fox
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

4.  Oxidative and nitrosative stress enzymes in relation to nitrotyrosine in Helicobacter pylori-infected humans.

Authors:  Anders Elfvin; Anders Edebo; Peter Hallersund; Anna Casselbrant; Lars Fändriks
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

Review 5.  Human and Helicobacter pylori Interactions Determine the Outcome of Gastric Diseases.

Authors:  Alain P Gobert; Keith T Wilson
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

6.  A novel genetic polymorphism of inducible nitric oxide synthase is associated with an increased risk of gastric cancer.

Authors:  Jing Shen; Run-Tian Wang; Li-Wei Wang; Yao-Chu Xu; Xin-Ru Wang
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

7.  Inducible nitric oxide synthase polymorphism is associated with the increased risk of differentiated gastric cancer in a Japanese population.

Authors:  Yasuyuki Goto; Takafumi Ando; Mariko Naito; Hidemi Goto; Nobuyuki Hamajima
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

8.  Involvement of Ras and AP-1 in Helicobacter pylori-induced expression of COX-2 and iNOS in gastric epithelial AGS cells.

Authors:  Soon Ok Cho; Joo Weon Lim; Kyung Hwan Kim; Hyeyoung Kim
Journal:  Dig Dis Sci       Date:  2009-06-03       Impact factor: 3.199

9.  Concurrent overexpression of serum p53 mutation related with Helicobacter pylori infection.

Authors:  Juan-Bosco Lopez-Saez; Victoria Gómez-Biondi; Germán Santamaría-Rodriguez; Margarita Dominguez-Villar; Antonio Amaya-Vidal; Antonio Lorenzo-Peñuelas; Avelino Senra-Varela
Journal:  J Exp Clin Cancer Res       Date:  2010-06-04

Review 10.  Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer.

Authors:  Shyam Singh; Hem Chandra Jha
Journal:  J Oncol       Date:  2017-03-21       Impact factor: 4.375

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.